Psychiatry and Neurology, Neurology · San Francisco, CA
NPI
1659307924
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
400 Parnassus Ave
San Francisco, CA, 94143
Phone (415) 353-2273
Groups this clinician bills Medicare through
Medicare paid, 2024
$60K
764 services
Medicare patients, 2024
275
Average age 64
Drug cost, 2024
$2.3M
5,057 prescriptions
Company payments, 2024
$13.4
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tina T Shih was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 198 times for 113 patients. In total Tina T Shih billed 764 services in 33 codes, and Medicare paid $60K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-06-09.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 198 | 113 | $13.17 | $2,608 |
| 99215 Office E&M - Established | Facility | 119 | 87 | $110.31 | $13K |
| 95718 Neurologic | Facility | 85 | 62 | $117.44 | $9,982 |
| 99214 Office E&M - Established | Facility | 82 | 60 | $76.69 | $6,288 |
| 95720 Neurologic | Facility | 71 | 43 | $182.60 | $13K |
| 99213 Office E&M - Established | Facility | 41 | 35 | $53.79 | $2,205 |
| 99205 Office E&M - New | Facility | 32 | 32 | $156.12 | $4,996 |
| 99212 Office E&M - Established | Facility | 29 | 21 | $21.61 | $627 |
| 99443 Telephone Services | Facility | 17 | 13 | $66.34 | $1,128 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 13 | 13 | $25.71 | $334 |
By year: 2022 $55K for 552 services; 2023 $44K for 464 services; 2024 $60K for 764 services.
Medicare prescription drug claims, 2024
In 2024, the drug Tina T Shih prescribed most often to Medicare patients was Lamotrigine, with 642 prescriptions and refills. In total Tina T Shih wrote 5,057 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Lamotrigine Generic | 642 | 1,244 | 111 | $12K |
| Levetiracetam Generic | 525 | 1,019 | 102 | $26K |
| Clobazam Generic | 358 | 409 | 47 | $54K |
| Zonisamide Generic | 246 | 469 | 47 | $10K |
| Carbamazepine Er Carbamazepine | 181 | 264 | 24 | $24K |
| Lorazepam Generic | 181 | 190 | 45 | $1,120 |
| Oxcarbazepine Generic | 180 | 345 | 27 | $18K |
| Clonazepam Generic | 166 | 197 | 30 | $1,795 |
| Topiramate Generic | 162 | 278 | 22 | $3,562 |
| Divalproex Sodium Er Divalproex Sodium | 151 | 319 | 32 | $19K |
| Lacosamide Generic | 150 | 193 | 23 | $23K |
| Lamotrigine Er Lamotrigine | 124 | 203 | 16 | $53K |
| Nayzilam Midazolam | 94 | 98 | 42 | $74K |
| Dilantin Phenytoin Sodium Extended | 84 | 134 | 14 | $22K |
| Lamictal Lamotrigine | 82 | 146 | Under 11 | $170K |
Brand drugs: 840 claims; generic drugs: 4,159 claims; opioid claims: 16.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Tina T Shih $13.4 ($13.4 in general payments such as food, travel and fees) from 1 company. The largest payer was Neurelis, Inc. with $13.4.
| Company | Payments | Amount |
|---|---|---|
| Neurelis, Inc. | 1 | $13.4 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.